Cyclo(-RGDfK) is a potent and selective inhibitor of the alphavbeta3 integrin, with an IC50 of 0.94 nM[1]. Cyclo(-RGDfK) TFA potently targets tumor microvasculature and cancer cells through the specific binding to the alphavbeta3 integrin on the cell surface[2].
Molecular Weight:
603.67
Purity:
98
CAS Number:
[161552-03-0]
Formula:
C27H41N9O7
Target:
Integrin
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted